Published in Scand J Gastroenterol on January 01, 1978
Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med (1999) 3.38
A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol (1999) 2.99
The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol (2000) 2.55
Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine (Baltimore) (1995) 1.97
Long-term outcome of Hemophilus influenzae meningitis related to antiobiotic treatment. Pediatrics (1977) 1.85
Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology (1998) 1.84
Antibody against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groups. Am J Epidemiol (1979) 1.79
A new antigen-antibody system. Clinical significance in long-term carriers of hepatitis B surface antigen. JAMA (1975) 1.78
Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Ann Rheum Dis (2008) 1.71
Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J Virol (1995) 1.71
Beta-blockers and lipid metabolism. Br Med J (1977) 1.68
[There is no reason to avoid calcium antagonists in hypertension]. Lakartidningen (1996) 1.62
Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population. J Infect Dis (1982) 1.59
Infection with delta agent in Sweden: introduction of a new hepatitis agent. J Infect Dis (1982) 1.55
Chronic liver disease in Ethiopia: a clinical study with emphasis on identifying common causes. Ethiop Med J (1992) 1.52
Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer. Oncogene (2011) 1.50
Transmission of Brucella melitensis. Lancet (1991) 1.49
Subtypes of Hepatitis B Antigen in Blood Donors and Post-transfusion Hepatitis: Clinical and Epidemiological Aspects. Br Med J (1973) 1.45
Toscana virus infection in German travellers returning from the Mediterranean. Infection (1997) 1.44
Hepatitis A, B, and delta infection in Ethiopia: a serologic survey with demographic data. Am J Epidemiol (1986) 1.39
19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis. J Am Soc Nephrol (1998) 1.34
Cytotoxic T-cell responses to the nucleocapsid proteins of HBV in chronic hepatitis. Evidence that antibody modulation may cause protracted infection. J Hepatol (1987) 1.33
Hepatitis A booster vaccination: is there a need? Lancet (2003) 1.32
Protection against hepatitis B virus infection by immunization with hepatitis B core antigen. Gastroenterology (1985) 1.32
Case of apparent reinfection with rubella. Lancet (1970) 1.31
HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection. Hepatology (1986) 1.31
HPV type-specific risks of high-grade CIN during 4 years of follow-up: a population-based prospective study. Br J Cancer (2007) 1.30
Advances in photoacoustic noninvasive glucose testing. Clin Chem (1999) 1.27
Clinical aspects of delta infection. Br Med J (Clin Res Ed) (1983) 1.25
Improved technique for detecting Australia antigen by immunoelectroosmophoresis. Vox Sang (1971) 1.24
Human papillomavirus DNA in urine samples compared with that in simultaneously collected urethra and cervix samples. J Clin Microbiol (1993) 1.24
Tourist hepatitis and gamma globulin prophylaxis. Scand J Infect Dis (1976) 1.23
Mother-to-infant transmission of hepatitis C virus. Ann Intern Med (1992) 1.23
Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: role of reactive oxygen species and regulation by histamine. Blood (2000) 1.22
Water intoxication associated with non-steroidal anti-inflammatory drug therapy. Acta Med Scand (1987) 1.18
Acute hepatitis A, B and non-A, non-B in a Swedish community studied over a ten-year period. Scand J Infect Dis (1982) 1.18
Detection of atovaquone and Malarone resistance conferring mutations in Plasmodium falciparum cytochrome b gene (cytb). Mol Cell Probes (2003) 1.14
Prevalence of hepatitis A and B infections in multiply transfused thalassaemic patients. Br Med J (1978) 1.13
Trigger factors and HL-A antigens in chronic active hepatitis. Br Med J (1975) 1.11
Human papillomavirus infection of the male diagnosed by Southern-blot hybridization and polymerase chain reaction: comparison between urethra samples and penile biopsy samples. J Med Virol (1991) 1.11
Cloning of hepatitis A virus genome. J Virol Methods (1981) 1.11
The epidemiological pattern of hepatitis A, B, and non-A, non-B in Sweden. Scand J Gastroenterol (1978) 1.10
Influence of twenty potentially antiviral substances on in vitro multiplication of hepatitis A virus. Antiviral Res (1986) 1.09
Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites. J Immunol (1996) 1.09
Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg. Hepatology (1993) 1.08
Mother to infant transmission of hepatitis C virus infection. J Med Virol (1990) 1.08
Subacute dysautonomia with incomplete recovery. Acta Neurol Scand (1972) 1.07
Typing of human papillomaviruses by consensus polymerase chain reaction and a non-radioactive reverse dot blot hybridization. J Virol Methods (1994) 1.07
Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites. J Immunol (1994) 1.07
Outbreak of acute hepatitis E virus infection among military personnel in northern Ethiopia. J Med Virol (1991) 1.06
Role of serotonin in the regulation of human natural killer cell cytotoxicity. J Immunol (1987) 1.05
[Vaccination or immunoglubulin against mumps?]. Lakartidningen (1977) 1.03
Hepatitis E virus infection in pregnancy in Ethiopia. Ethiop Med J (1993) 1.01
Sites that bind polymerized albumin on hepatitis B surface antigen particles: detection by radioimmunoassay. Infect Immun (1979) 1.01
Genital HPV infection not a local but a regional infection: experience from a female teenage group. Genitourin Med (1993) 1.00
Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee. J Med Virol (1985) 1.00
Serotonin protects NK cells against oxidatively induced functional inhibition and apoptosis. J Leukoc Biol (2001) 0.99
Increased occurrence of hepatitis A with cyclic outbreaks among drug addicts in a Swedish community. Infection (1983) 0.99
Multiple attacks of hepatitis in drug addicts: biochemical, immunochemical, and morphologic characteristics. J Infect Dis (1973) 0.98
The herpes simplex virus encephalitis in mice at different environmental temperatures. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 0.98
Immunopathologic aspects of woodchuck hepatitis. Am J Pathol (1984) 0.98
Mucosal human papillomavirus types in squamous cell carcinomas of the uterine cervix and subsequently on fingers. Br J Dermatol (2000) 0.97
Histamine protects T cells and natural killer cells against oxidative stress. J Interferon Cytokine Res (1999) 0.97
Enzyme-linked immunosorbent assay for detection of immunoglobulin M antibody to hepatitis B core antigen. J Clin Microbiol (1981) 0.97
Hepatitis-associated antigen and antibody in Swedish blood donors. Relation to liver disease. Vox Sang (1972) 0.96
Histamine H2-receptor-mediated regulation of human natural killer cell activity. J Immunol (1986) 0.96
Transmission of hepatitis B virus infection in Ethiopia with emphasis on the importance of vertical transmission. Int J Epidemiol (1988) 0.96
The effect of clonidine and penbutolol, respectively on catecholamines in blood and urine, plasma renin activity and urinary aldosterone in hypertensive patients. Arch Int Pharmacodyn Ther (1975) 0.96
Serotonergic 5-HT1A receptors regulate a cell contact-mediated interaction between natural killer cells and monocytes. Scand J Immunol (1993) 0.96
e antigen in acute hepatitis B. Br Med J (1976) 0.96
Structural studies of acetan, an exopolysaccharide elaborated by Acetobacter xylinum. Carbohydr Res (1993) 0.95
Woodchuck hepatitis virus infection: serologic and histopathologic course and outcome. Eur J Clin Microbiol (1985) 0.95
Nitrofurantoin-induced chronic liver disease. Clinical course and outcome of five cases. Scand J Gastroenterol (1979) 0.95
Hepatitis B virus DNA, HBeAg and delta infection during the course from acute to chronic hepatitis B virus infection. Hepatology (1985) 0.95
Delta agent infection in Melbourne. J Med Virol (1984) 0.95
Immunization of haemophiliacs against hepatitis B. A joint study between the haemophilia centers in Leuven, Belgium and Malmö, Sweden. Scand J Haematol Suppl (1984) 0.95
Interferon and natural killer cells in systemic lupus erythematosus. Clin Exp Immunol (1982) 0.95
Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms. Eur J Neurosci (1996) 0.95
Hepatitis C superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney. Transplantation (1995) 0.94
Acute sporadic viral hepatitis in Ethiopia: causes, risk factors, and effects on pregnancy. Clin Infect Dis (1992) 0.94
Phylogenetic analysis of hepatitis D viruses indicating a new genotype I subgroup among African isolates. J Clin Microbiol (1996) 0.94
Serological survey of human immunodeficiency virus infection in Ethiopia. Ethiop Med J (1988) 0.94
Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays. J Med Virol (1991) 0.93
Therapy of secondary hyperparathyroidism with 19-nor-1alpha,25-dihydroxyvitamin D2. Am J Kidney Dis (1998) 0.93
A microcarrier cell culture system for large scale production of hepatitis A virus. J Virol Methods (1984) 0.92
Cerebrospinal fluid concentrations of trimethoprim during oral and parenteral treatment. J Antimicrob Chemother (1979) 0.92
Patterns of immunoglobulins in acute viral hepatitis: relation to hepatitis-associated antigen. J Infect Dis (1972) 0.92
Joint occurrence of human papillomavirus type 16 DNA in Bowen's disease on a finger and in dysplasia of the vulva and the uterine cervix. Br J Dermatol (1994) 0.92
Hepatitis C virus infection and chronic liver disease in Ethiopia where hepatitis B infection is hyperendemic. Trans R Soc Trop Med Hyg (1995) 0.91